-
Alternative_name
[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate; Prezista; TMC114; (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate; N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide; UIC-94017
-
Description
Darunavir is an HIV-1 protease inhibitor with an IC₅₀ of 3 nM and cytoxicity of 74.4 μM. It is also also active against wild-type and multidrug-resistant clinical isolates of HIV-1 in phytohemagglutinin-activated peripheral blood mononuclear cells. Modelling studies have shown that darunavir can bind to papain like viral protease and may be beneficial in treating SARS-COV-2.
-
CAS Number
206361-99-1
-
Structure Available
1
-
Molecular Formula
C₂₇H₃₇N₃O₇S
-
Molecular Weight
547.7
-
Cell Permeable
True
-
Purity
≥ 98%
-
Solubilities
~30 mg/ml in DMF, ~25 mg/ml in DMSO
-
Handling
Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
-
Tag Line
An HIV-1 protease inhibitor
-
Storage Condition
-20ºC
-
Shipping Condition
RT
-
Shelf Life
36 months
-
MDL Number
MFCD09260006
-
PubChem CID
213039
-
-
SMILES
CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N
-
InChi
InChI=1S/C27H37N3O7S/c1-18(2)15-30(38(33,34)21-10-8-20(28)9-11-21)16-24(31)23(14-19-6-4-3-5-7-19)29-27(32)37-25-17-36-26-22(25)12-13-35-26/h3-11,18,22-26,31H,12-17,28H2,1-2H3,(H,29,32)/t22-,23-,24+,25-,26+/m0/s1
-
InChi Key
CJBJHOAVZSMMDJ-HEXNFIEUSA-N
-
-
MSDS Available
1